Reuters logo
BRIEF-Foamix Pharmaceuticals appoints David Domzalski as CEO
2017年6月29日 / 中午12点27分 / 3 个月前

BRIEF-Foamix Pharmaceuticals appoints David Domzalski as CEO

June 29 (Reuters) - Foamix Pharmaceuticals Ltd:

* Foamix Pharmaceuticals appoints David Domzalski as chief executive officer

* Foamix Pharmaceuticals Ltd - Domzalski succeeds Dov Tamarkin as CEO

* Foamix Pharmaceuticals Ltd - Tamarkin will continue to be a member of company’s Board of directors and will serve as chief scientific advisor to Foamix

* Foamix Pharmaceuticals Ltd - Ilan Hadar, current CFO of Foamix, will assume role of country manager in Israel, in addition to his role as CFO Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below